User:Mr. Ibrahem/Lonapegsomatropin

Lonapegsomatropin, sold under the brand name Skytrofa, is a medication used to treat growth hormone deficiency. It may be used in children from the ages of 1 to 18 year. It is given by injection under the skin once per week.

Common side effects include headache, joint pain, low thyroid, and pain at the site of injection. Other side effects may include allergic reactions, cancer, diabetes, intracranial hypertension, swelling, pancreatitis, and slipped capital femoral epiphysis. It is a human growth hormone (somatropin) that has been developed to be long acting.

Lonapegsomatropin was approved for medical use in the United States in 2021 and Europe in 2022. In the United States it costs 2,800 to 12,300 USD per week, depending on the weight of the child. As of 2022 it is not yet commercial available in Europe.